US Broker Ratings

UroGen Pharma Ltd. (URGN) Investor Outlook: Analyzing the 131% Potential Upside

UroGen Pharma Ltd. (NASDAQ: URGN) has captured the attention of investors with its robust potential upside, as evidenced by a striking 131.17% when comparing the current..

Immutep Limited (IMMP) Stock Analysis: Exploring a Potential 490% Upside in the Biotech Sector

Immutep Limited (NASDAQ: IMMP), an Australian biotechnology firm, has caught the attention of investors with its significant potential upside of 490.06%. Specializing in pioneering immunotherapies targeting..

AudioEye, Inc. (AEYE) Stock Analysis: A Small Cap Tech Player with a 92% Upside Potential

AudioEye, Inc. (NASDAQ: AEYE), a dynamic player in the technology sector, presents a compelling investment opportunity with a potential upside of 92.11%, according to recent analyst..

Rigel Pharmaceuticals (RIGL) Stock Analysis: Unpacking the 74% Potential Upside

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) has captured the attention of the biotech investment community with a potential upside of 74.29%, positioning it as a compelling opportunity..

Canopy Growth Corporation (CGC) Stock Analysis: Evaluating the 78.81% Potential Upside

For investors keeping an eye on the healthcare sector, particularly within the burgeoning cannabis industry, Canopy Growth Corporation (CGC) presents an intriguing, albeit risky, opportunity. Operating..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring a Potential 191.61% Upside in the Biotechnology Sector

Entrada Therapeutics, Inc. (NASDAQ: TRDA), a burgeoning name in the biotechnology industry, has been capturing the attention of investors with its groundbreaking approach to treating neuromuscular..

iTeos Therapeutics, Inc. (ITOS) Stock Analysis: A Biotech Play with 10% Upside Potential

iTeos Therapeutics, Inc. (NASDAQ: ITOS) is a clinical-stage biopharmaceutical company that has caught the attention of investors seeking opportunities within the healthcare sector, specifically the biotechnology..

Absci Corporation (ABSI) Stock Analysis: Unveiling a 231.82% Potential Upside in AI-Driven Biotechnology

Absci Corporation (NASDAQ: ABSI) stands at the intersection of healthcare and cutting-edge technology, making waves in the biotechnology sector with its innovative approach to drug creation...

ZoomInfo Technologies Inc. (GTM) Stock Analysis: Uncovering a 13.67% Upside in a Challenging Market

ZoomInfo Technologies Inc. (NASDAQ: GTM), a key player in the Software – Application industry, continues to capture investor attention with its comprehensive go-to-market intelligence platform. Despite..

A2Z Cust2Mate Solutions Corp. (AZ) Stock Analysis: Is a 91.75% Upside Within Reach?

Investors are casting a keen eye on A2Z Cust2Mate Solutions Corp. (AZ), a Canadian technology firm that is making waves with its innovative retail solutions. The..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating Market Challenges with Strategic Insights

Zhengye Biotechnology Holding Limited (ZYBT), a key player in the healthcare sector focusing on the development and manufacture of veterinary vaccines, presents an intriguing case for..

Varex Imaging Corporation (VREX) Investor Outlook: A Healthcare Stock with Over 116% Potential Upside

Varex Imaging Corporation (NASDAQ: VREX), a key player in the healthcare sector’s medical devices industry, presents a compelling case for investors with its substantial potential upside..

Tvardi Therapeutics, Inc. (TVRD): Investor Outlook on a Biotech Challenger with 119% Potential Upside

Tvardi Therapeutics, Inc. (TVRD) is a name that is capturing the attention of investors in the biotechnology sector, particularly those with an appetite for high-reward opportunities...

aTyr Pharma, Inc. (ATYR) Stock Analysis: Exploring the 258.80% Potential Upside

Investors with an eye on the biotechnology sector may find aTyr Pharma, Inc. (NASDAQ: ATYR) an intriguing proposition. This San Diego-based clinical-stage biotech company is pioneering..

Nano-X Imaging Ltd (NNOX) Stock Analysis: A 73% Potential Upside in the Rapidly Evolving Medical Devices Sector

Nano-X Imaging Ltd (NNOX), a key player in the medical devices industry, has been making waves with its innovative approach to medical imaging. Headquartered in Petah..

Alumis Inc. (ALMS) Stock Analysis: Exploring a Potential 597.67% Upside in the Biotech Sector

Alumis Inc. (ALMS), a promising player in the biotechnology industry, is catching the attention of investors with its significant upside potential. With a market capitalization of..

Heron Therapeutics, Inc. (HRTX) Stock Analysis: Exploring a 212.50% Potential Upside in the Biotechnology Sector

Heron Therapeutics, Inc. (HRTX) is making waves in the biotechnology sector, with its innovative approach to improving medical care through its proprietary drug delivery technology, Biochronomer...

Viant Technology Inc. (DSP) Stock Analysis: Eyeing a 66% Upside Potential with Robust Revenue Growth

Viant Technology Inc. (NASDAQ: DSP), an innovative player in the technology sector, has caught the attention of investors with its impressive revenue growth and potential upside...

Anbio Biotechnology (NNNN) Stock Analysis: A Closer Look at Its Impressive 104% Yearly Growth

In the fast-evolving landscape of medical technology, Anbio Biotechnology (NNNN) has carved out a niche for itself, offering innovative in vitro diagnostics (IVD) products to a..

Marti Technologies, Inc. (MRT): An Investor Outlook on Potential 97% Upside

Marti Technologies, Inc. (NASDAQ: MRT), a dynamic player in the technology sector, is capturing investor attention with its unique position in the software application industry. Headquartered..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds